|
1
|
Schipper RJ, van Roozendaal LM, de Vries
B, Pijnappel RM, Beets-Tan RG, Lobbes MB and Smidt ML: Axillary
ultrasound for preoperative nodal staging in breast cancer
patients: Is it of added value? Breast. 22:1108–1113.
2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Humphrey KL, Saksena MA, Freer PE, Smith
BL and Rafferty EA: To do or not to do: Axillary nodal evaluation
after ACOSOG Z0011 trial. Radiographics. 34:1807–1816.
2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Giuliano AE, Ballman K, McCall L, Beitsch
P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M and
Hunt KK: Locoregional recurrence after sentinel lymph node
dissection with or without axillary dissection in patients with
sentinel lymph node metastases: Long-term follow-up from the
american college of surgeons oncology group (Alliance) ACOSOG Z0011
randomized trial. Ann Surg. 264:413–420. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Giuliano AE, Ballman KV, McCall L, Beitsch
PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW,
Blumencranz PW, et al: Effect of axillary dissection vs. no
axillary dissection on 10-year overall survival among women with
invasive breast cancer and sentinel node metastasis. The ACOSOG
Z0011 (Alliance) randomized clinical trial. JAMA. 318:918–926.
2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lee J, Choi JE, Kim SJ, Lee SB, Seong MK,
Jeong J, Yoon CS, Kim BK and Sun WY: Korean Breast Cancer Society.
Comparative study between sentinel lymph node biopsy and axillary
dissection in patients with one or two lymph node metastases. J
Breast Cancer. 21:306–314. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tsujimoto M, Nakabayashi K, Yoshidome K,
Kaneko T, Iwase T, Akiyama F, Kato Y, Tsuda H, Ueda S, Sato K, et
al: One-step nucleic acid amplification for intraoperative
detection of lymph node metastasis in breast cancer patients. Clin
Cancer Res. 13:4807–4816. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Di Filippo F, Giannarelli D, Bouteille C,
Bernet L, Cano R, Cunnick G and Sapino A: Elaboration of a nomogram
to predict non sentinel node status in breast cancer patients with
positive sentinel node, intra-operatively assessed with o nucleic
acid amplification method. J Exp Clin Cancer Res.
34(136)2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Peg V, Espinosa-Bravo M, Vieites B,
Vilardell F, Antúnez JR, de Salas MS, Delgado-Sánchez JJ, Pinto W,
Gozalbo F, Petit A, et al: Intraoperative molecular analysis of
total tumor load in sentinel lymph node: A new predictor of
axillary status in early breast cancer patients. Breast Cancer Res
Treat. 139:87–93. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Koca B, Kuru B, Ozen N, Yoruker S and Bek
Y: A breast cancer nomogram for prediction of non-sentinel node
metastasis-validation of fourteen existing models. Asian Pac J
Cancer Prev. 15:1481–1488. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fung V, Kohlhardt S, Vergani P, Zardin GJ
and Williams NR: Intraoperative prediction of the two axillary
lymph node macrometastases threshold in patients with breast cancer
using a one-step nucleic acid cytokeratin-19 amplification assay.
Mol Clin Oncol. 7:755–762. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Peg V, Sansano I, Vieites B, Bernet L,
Cano R, Córdoba A, Sancho M, Martín MD, Vilardell F, Cazorla A, et
al: Role of total tumour load of sentinel lymph node on survival in
early breast cancer patients. Breast. 33:8–13. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Intraoperative tests (RD-100i OSNA system
and Metasin test) for detecting sentinel lymph node metastases in
breast cancer. NICE diagnostics guidance 8, 2013. Available from:
http://www.nice.org.uk/dg8.
|
|
13
|
Raia-Barjat T, Trombert B, Khaddage A,
Douchet C, Seffert P, Peoc'h M, Falk AT, Magné N and Chauleur C:
OSNA (one-step nucleic acid amplification) sentinel lymph node
intraoperative molecular analysis in breast cancer: A cost-benefit
analysis. Med Oncol. 31(322)2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Brambilla T, Fiamengo B, Tinterri C,
Testori A, Grassi MM, Sciarra A, Abbate T, Gatzemeier W, Roncalli M
and Di Tommaso L: One-step nucleic acid amplification in breast
cancer sentinel lymph node: A single institutional experience and a
short review. Front Med (Lausanne). 2(37)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Stachs A, Thi AT, Dieterich M, Stubert J,
Hartmann S, Glass Ä, Reimer T and Gerber B: Assessment of
ultrasound features predicting axillary nodal metastasis in breast
cancer: The impact of cortical thickness. Ultrasound Int Open.
1:E19–E24. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cho N, Moon WK, Han W, Park IA, Cho J and
Noh DY: Preoperative sonographic classification of axillary lymph
nodes in patients with breast cancer: Node-to-node correlation with
surgical histology and sentinel node biopsy results. AJR Am J
Roentgenol. 193:1731–1737. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bedi DG, Krishnamurthy R, Krishnamurthy S,
Edeiken BS, Le-Petross H, Fornage BD, Bassett RL Jr and Hunt KK:
Cortical morphologic features of axillary lymph nodes as a
predictor of metastasis in breast cancer: In vitro sonographic
study. AJR Am J Roentgenol. 191:646–652. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yang WT, Chang J and Metreweli CL:
Patients with breast cancer: Differences in color doppler flow and
gray-scale US features of benign and malignant axillary lymph
nodes. Radiology. 215:568–573. 2000.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Mansel RE, MacNeill F, Horgan K, Goyal A,
Britten A, Townson J, Clarke D, Newcombe R and Keshtgar M:
Guildford Breast Surgeons et al. Results of a national
training programme in sentinel lymph node biopsy for breast cancer.
Br J Surg. 100:654–661. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
NHS Cancer Screening Programmes/Royal
College of Pathologists: Pathology Reporting of Breast Disease.
NHSBSP publication no. 58, 2005. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/541521/pathology_reporting_of_breast_disease.pdf.
Accessed May 21, 2016.
|
|
21
|
Galimberti V, Cole BF, Zurrida S, Viale G,
Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, et
al: Axillary dissection versus no axillary dissection in patients
with sentinel-node micrometastases (IBCSG 23-01): A phase 3
randomised controlled trial. Lancet Oncol. 14:297–305.
2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Glechner A, Wöckel A, Gartlehner G, Thaler
K, Strobelberger M, Griebler U and Kreienberg R: Sentinel lymph
node dissection only versus complete axillary lymph node dissection
in early invasive breast cancer: A systematic review and
meta-analy. Eur J Cancer. 49:812–825. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Straver ME, Meijnen P, van Tienhoven G,
van de Velde CJ, Mansel RE, Bogaerts J, Demonty G, Duez N,
Cataliotti L, Klinkenbijl J, et al: Role of axillary clearance
after a tumor-positive sentinel node in the administration of
adjuvant therapy in early breast cancer. J Clin Oncol. 28:731–737.
2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Caudle AS, Hunt KK, Tucker SL, Hoffman K,
Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera
GV, et al: American college of surgeons oncology group (ACOSOG)
Z0011: Impact on surgeon practice patterns. Ann Surg Oncol.
19:3144–3151. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gainer SM, Hunt KK, Beitsch P, Caudle AS,
Mittendorf EA and Lucci A: Changing behavior in clinical practice
in response to the ACOSOG Z0011 trial: A survey of the American
society of breast surgeons. Ann Surg Oncol. 19:3152–3158.
2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Houssami N, Ciatto S, Turner RM, Cody HS
III and Macaskill P: Preoperative ultrasound-guided needle biopsy
of axillary nodes in invasive breast cancer: Meta-analysis of its
accuracy and utility in staging the axilla. Ann Surg. 254:243–251.
2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Caudle AS, Kuerer HM, Le-petross HT, Yang
W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK and
Mittendorf EA: Predicting the extent of nodal disease in
early-stage breast cancer. Ann Surg Oncol. 21:3440–3447.
2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Pilewskie M, Mautner SK, Stempel M, Eaton
A and Morrow M: Does a positive axillary lymph node needle biopsy
result predict the need for an axillary lymph node dissection in
clinically node-negative breast cancer patients in the ACOSOG Z0011
era? Ann Surg Oncol. 23:1123–1128. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ahmed M, Jozsa F, Baker R, Rubio IT,
Benson J and Douek M: Meta-analysis of tumour burden in
pre-operative axillary ultrasound positive and negative breast
cancer patients. Breast Cancer Res Treat. 166:329–336.
2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hieken TJ, Trull BC, Boughey JC, Jones KN,
Reynolds CA, Shah SS and Glazebrook KN: Preoperative axillary
imaging with percutaneous lymph node biopsy is valuable in the
contemporary management of patients with breast cancer. Surgery.
154:831–840. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Harris CK, Tran HT, Lee K, Mylander C,
Pack D, Rosman M, Tafra L, Umbricht CB, Andrade R, Liang W and
Jackson RS: Positive ultrasound-guided lymph node needle biopsy in
breast cancer may not mandate axillary lymph node dissection. Ann
Surg Oncol. 24:3004–3010. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Stachs A, Göde K, Hartmann S, Stengel B,
Nierling U, Dieterich M, Reimer T and Gerber B: Accuracy of
axillary ultrasound in preoperative nodal staging of breast
cancer-size of metastases as limiting factor. Springerplus.
2(350)2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lee B, Lim AK, Krell J, Satchithananda K,
Coombes RC, Lewis JS and Stebbing J: The efficacy of axillary
ultrasound in the detection of nodal metastasis in breast cancer.
Am J Roentgenol. 200:314–320. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Moorman AM, Bourez RL, Heijmans HJ and
Kouwenhoven EA: Axillary ultrasonography in breast cancer patients
helps in identifying patients preoperatively with limited disease
of the axilla. Ann Surg Oncol. 21:2904–2910. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Verheuvel NC, van den Hoven I, Ooms HW,
Voogd AC and Roumen RM: The role of ultrasound-guided lymph node
biopsy in axillary staging of invasive breast cancer in the
post-ACOSOG Z0011 trial era. Ann Surg Oncol. 22:409–415.
2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Goyal A, Newcombe RG and Mansel RE:
Axillary Lymphatic Mapping Against Nodal Axillary Clearance
(ALMANAC) Trialists Group. Clinical relevance of multiple sentinel
nodes in patients with breast cancer. Br J Surg. 92:438–442.
2005.PubMed/NCBI View
Article : Google Scholar
|
|
37
|
Goyal A, Newcombe RG, Chhabra A and Mansel
RE: ALMANAC Trialists Group. Factors affecting failed localisation
and false-negative rates of sentinel node biopsy in breast
cancer-results of the ALMANAC validation phase. Breast Cancer Res
Treat. 99:203–208. 2006.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Donker M, van Tienhoven G, Straver ME,
Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH,
Klinkenbijl JH, Orzalesi L, et al: Radiotherapy or surgery of the
axilla after a positive sentinel node in breast cancer (EORTC
10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3
non-inferiority trial. Lancet Oncol. 15:1303–1310. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Krag DN, Anderson SJ, Julian TB, Brown AM,
Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP,
Jalovec LM, et al: Sentinel-lymph-node resection compared with
conventional axillary-lymph-node dissection in clinically
node-negative patients with breast cancer: Overall survival
findings from the NSABP B-32 randomised phase 3 trial. Lancet
Oncol. 11:927–933. 2010.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kohrt HE, Olshen RA, Bermas HR, Goodson
WH, Wood DJ, Henry S, Rouse RV, Bailey L, Philben VJ, Dirbas FM, et
al: New models and online calculator for predicting non-sentinel
lymph node status in sentinel lymph node positive breast cancer
patients. BMC Cancer. 8(66)2008.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Fujisue M, Nishimura R, Okumura Y, Tashima
R, Nishiyama Y, Osako T, Toyozumi Y and Arima N: Clinical
significance of CK19 negative breast cancer. Cancers (Basel).
5:1–11. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Bergkvist L, de Boniface J, Jönsson PE,
Ingvar C, Liljegren G and Frisell J: Swedish Society of Breast
Surgeons. Axillary recurrence rate after negative sentinel node
biopsy in breast cancer: Three year follow-up of the Swedish
multicenter cohort study. Ann Surg. 247:150–156. 2008.PubMed/NCBI View Article : Google Scholar
|
|
43
|
National Comprehensive Cancer Network.
Breast Cancer (Version 4.2020). Available at: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.
Accessed May 11, 2020.
|
|
44
|
International Breast Cancer Study Group.
Rudenstam CM, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey
P, Dent D, Campbell I, Bernhard J, et al: Randomized trial
comparing axillary clearance versus no axillary clearance in older
patients with breast cancer: First results of international breast
cancer study group trial 10-93. J Clin Oncol. 24:337–344.
2006.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Martelli G, Boracchi P, Ardonino I, Lozza
L, Bohm S, Vetrella G and Agresti R: Axillary dissection versus no
axillary dissection in older patients with T1N0 breast cancer:
15-year results of a randomized controlled trial. Ann Surg.
256:920–924. 2012.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Agresti R, Martelli G, Sandri M, Tagliabue
E, Carcangiu ML, Maugeri I, Pellitteri C, Ferraris C, Capri G,
Moliterni A, et al: Axillary lymph node dissection versus no
dissection in patients with T1N0 breast cancer: A randomized
clinical trial (INT09/98). Cancer. 120:885–893. 2014.PubMed/NCBI View Article : Google Scholar
|
